Joel Bolen, MD
Geriatric Medicine · Montgomery, ALNPI 1063576130
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 212 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 38 manufacturers reported payments, led by Sunovion Pharmaceuticals Inc. at 24.0% of the total. Reporting peaked in 2020 at $943 and has fallen 67.8% since, to $304 in 2025. Among geriatric medicine clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 212 payments — averaging $18.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$946
- Pfizer$349
- Biogen$185
- Otsuka America Pharmaceutical, Inc.$160
- AbbVie$150
- Johnson & Johnson$143
- plus $2K from 32 others
What the payments were for
- Food & beverage$3,87898%
- Education$652%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 56 | $946 |
| Pfizer | 23 | $349 |
| Biogen | 10 | $185 |
| Otsuka America Pharmaceutical, Inc. | 9 | $160 |
| AbbVie(2 entities) | 7 | $150 |
| Johnson & Johnson | 6 | $143 |
| Amgen | 4 | $119 |
| Novartis | 7 | $119 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $119 |
| Lilly USA, LLC | 7 | $118 |
| UCB, Inc. | 5 | $116 |
| Collegium Pharmaceutical, Inc. | 6 | $114 |
| Eisai Inc. | 4 | $112 |
| Mylan Specialty L.p. | 5 | $90 |
| Amneal Pharmaceuticals LLC | 5 | $86 |
| Nestle Healthcare Nutrition Inc. | 4 | $86 |
| Lundbeck LLC | 4 | $77 |
| Avanir Pharmaceuticals, Inc. | 5 | $74 |
| Boehringer Ingelheim | 4 | $74 |
| Novo Nordisk | 2 | $65 |
| Teva Pharmaceuticals USA, Inc. | 3 | $63 |
| Acadia Pharmaceuticals Inc | 3 | $54 |
| Avion Pharmaceuticals | 3 | $53 |
| Astellas Pharma US Inc | 4 | $53 |
| SK Life Science, Inc. | 2 | $52 |
| Alpha Cognition USA, Inc. | 1 | $49 |
| E.r. Squibb & Sons, L.L.C. | 2 | $42 |
| Romark Laboratories, LC | 2 | $40 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
| AstraZeneca | 2 | $34 |
| Dexcom, Inc. | 2 | $33 |
| Radius Health, Inc. | 1 | $29 |
| GE HealthCare | 1 | $24 |
| Vivus LLC | 1 | $19 |
| Neurocrine Biosciences, Inc. | 1 | $17 |
| Verona Pharma, Inc. | 1 | $16 |
| Exact Sciences | 1 | $15 |
| Smith+Nephew | 1 | $14 |
How this compares
$3,943 in reported general payments places this provider in the 90th percentile of 39 geriatric medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 608 | $279,664 |
| JardianceEmpagliflozin | 153 | $151,138 |
| OxycontinOxycodone Hcl | 82 | $101,391 |
| JanuviaSitagliptin Phosphate | 182 | $98,442 |
| AptiomEslicarbazepine Acetate | 137 | $94,505 |
| EntrestoSacubitril/Valsartan | 144 | $87,300 |
| XareltoRivaroxaban | 207 | $86,064 |
| MyrbetriqMirabegron | 162 | $82,652 |
| LinzessLinaclotide | 100 | $71,624 |
| Xtampza ErOxycodone Myristate | 94 | $68,486 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,828 | $64,568 |
| OzempicSemaglutide | 48 | $59,015 |
| TradjentaLinagliptin | 105 | $51,282 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 68 | $49,660 |
| IngrezzaValbenazine Tosylate | 12 | $43,800 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $349 | $279,664608 claims |
| Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat | $74 | $214,769283 claims |
| Sunovion Pharmaceuticals Inc.Aptiom | $946 | $94,505137 claims |
| NovartisEntresto | $119 | $87,300144 claims |
| Johnson & JohnsonXarelto | $143 | $86,064207 claims |
| AstraZenecaBreztri Aerosphere, Farxiga, Symbicort | $34 | $85,069139 claims |
| Astellas Pharma US IncMyrbetriq | $53 | $82,652162 claims |
| AbbVieLinzess | $150 | $71,624100 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $114 | $68,48694 claims |
| Novo NordiskOzempic | $65 | $59,01548 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $17 | $43,80012 claims |
| Lilly USA, LLCTrulicity | $118 | $42,37229 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 39 geriatric medicine providers in Alabama.
Other geriatric medicine in Montgomery
- Dorothy ThompsonMontgomery$227
- Donald VollmerHuntsville$229K
- Arden AylorTalladega$5K
- Ali AhmedBirmingham$3K
- Russell UlrichPiedmont$2K
- Juanita HeersinkDothan$2K
- David RaderMountain Brk$2K
- Igor BidikovHeflin$1K
- Julie KnopEva$741
- Jaehneth Ewell-TaylorTuskegee$379
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.